Globus Medical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.About GMED
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders.
GMED Key Statistics
Stock Snapshot
The current Globus Medical(GMED) stock price is $90.59, with a market capitalization of 12.19B. The stock trades at a price-to-earnings (P/E) ratio of 29.64.
On 2026-01-14, Globus Medical(GMED) stock traded between a low of $89.18 and a high of $90.83. Shares are currently priced at $90.59, which is +1.6% above the low and -0.3% below the high.
Globus Medical(GMED) shares are trading with a volume of 281.22K, against a daily average of 1.9M.
During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $101.40 at its peak.
During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $101.40 at its peak.
GMED News
Globus Medical, Inc. recently reported preliminary unaudited results showing fourth-quarter 2025 sales of about US$823.2 million and full-year 2025 sales of rou...
Globus Medical (GMED) is back in focus after management issued new guidance that points to fourth quarter 2025 sales of about US$823.2 million and full year 202...
BTIG analyst Ryan Zimmerman has maintained their neutral stance on GMED stock, giving a Hold rating today. Claim 70% Off TipRanks Premium Unlock hedge fund-leve...
Analyst ratings
56%
of 16 ratingsMore GMED News
Needham analyst David Saxon has maintained their neutral stance on GMED stock, giving a Hold rating yesterday. Claim 70% Off TipRanks Premium Unlock hedge fund-...
Management sees a strong end to fiscal 2025. After falling almost 3% during regular trading hours today, shares of Globus Medical (GMED 2.95%) are heading in t...
Stock futures were mixed following a mixed trading day as investors took profits and shifted focus to this week’s economic data. Meanwhile, comments from Presid...
“We’re thrilled with our preliminary Q4 results, capping off a strong finish to 2025,” commented Keith Pfeil, President and Chief Executive Officer. “Globus clo...